Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Substance Use and Addictions Program

CUPS Calgary Society

$1,808,048.00

Opioid Agonist Therapy (OAT) Intensive Case Management

EF 2024-25 · 2024-10-02

Résumé
This project will provide an Intensive Case Management program for low-income individuals with a history of complex opioid and/or polysubstance use who are discharged from treatment settings including acute care. Individuals will be connected to Opioid Agonist Therapy (methadone, Buprenorphine, Sublocade, and Kadian) and other wraparound care such as primary care, mental health counselling, economic support, housing, and prenatal care.
Ministère
Programme
Substance Use and Addictions ProgramSubstance Use and Addictions Program (lien de confiance élevée)
Bénéficiaire
Emplacement
Calgary, Alberta, Canada
Type de bénéficiaire
Other
Numéro d'entreprise
134112515
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

Tel que publié

Agreement End Date
2028-03-31
Agreement Number
2425-HQ-000015
Agreement Start Date
2024-10-02
Agreement Title
Opioid Agonist Therapy (OAT) Intensive Case Management
Agreement Title (French)
Opioid Agonist Therapy (OAT) Intensive Case Management
Agreement Type
Contribution
Agreement Value
$1,808,048.00
Amendment Number
0
Description
This project will provide an Intensive Case Management program for low-income individuals with a history of complex opioid and/or polysubstance use who are discharged from treatment settings including acute care. Individuals will be connected to Opioid Agonist Therapy (methadone, Buprenorphine, Sublocade, and Kadian) and other wraparound care such as primary care, mental health counselling, economic support, housing, and prenatal care.
Description (French)
Cette initiative fournir un programme de gestion intensive des cas pour les personnes à faible revenu ayant des antécédents de consommation complexe d'opioïdes et/ou de polytoxicomanie qui sortent d'un environnement de traitement, y compris de soins aigus. Les personnes seront dirigées vers un traitement par agonistes opioïdes (méthadone, buprénorphine, Sublocade et Kadian) et d'autres soins complémentaires, comme les soins primaires, les conseils en santé mentale, le soutien économique, le logement et les soins prénataux.
Expected Results
Targeted stakeholders and Canadians access evidence-informed information related to substance use and are equipped with the capacity (knowledge, skills and supports) to inform their decisions and actions related to substance use.
Expected Results (French)
Les intervenants et les Canadiens ciblés ont accès à des renseignements fondés sur des données probantes concernant la consommation de substances et ont la capacité (connaissances, compétences et soutien) d’éclairer leurs décisions et actions en matière de consommation de substances.
Organization Code
hc-sc
Organization
Health Canada | Santé Canada
Program Name
Substance Use and Addictions Program
Program Name (French)
Programme sur l’usage et les dépendances aux substances
Program Purpose
Health Protection and Promotion
Program Purpose (French)
Protection et promotion de la santé
Recipient Business Number
134112515
Recipient City
Calgary
Recipient Country
CA
Recipient Legal Name
CUPS Calgary Society
Recipient Postal Code
T2R 0B7
Recipient Province or Territory
AB
Recipient Type
O
Reference Number
271-2024-2025-Q3-00011